يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Long, Yi-Xiu"', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
    دورية أكاديمية
    First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component

    المؤلفون: Zhou, Yu‐Wen, Long, Yi‐Xiu, Chen, Ye, Liu, Ji‐Yan, Pu, Dan, Huang, Jia‐Yan, Bi, Feng, Li, Qiu, Gou, Hong‐Feng, Qiu, Meng

    المصدر: Cancer Medicine ; volume 10, issue 10, page 3388-3402 ; ISSN 2045-7634 2045-7634

    الإتاحة: https://doi.org/10.1002/cam4.3876Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas

    المؤلفون: Zhou, Yu‐Wen, Long, Yi‐Xiu, Song, Kun, Liang, Li‐Bo, Cheng, Ke, Chen, Ye, Liu, Ji‐Yan

    المصدر: Cancer Medicine ; volume 10, issue 16, page 5415-5428 ; ISSN 2045-7634 2045-7634

    الإتاحة: https://doi.org/10.1002/cam4.4053Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Tumor calcification is associated with better survival in metastatic colorectal cancer patients treated with bevacizumab plus chemotherapy

    المؤلفون: Zhou, Yu-Wen, Long, Yi-Xiu, Liu, Xia, Liu, Ji-Yan, Qiu, Meng

    المساهمون: The 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University, National Key Development Plan for Precision Medicine Research

    المصدر: Future Oncology ; volume 18, issue 22, page 2453-2464 ; ISSN 1479-6694 1744-8301

    الإتاحة: https://doi.org/10.2217/fon-2021-1422Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Immune-Related Pneumonitis Was Decreased by Addition of Chemotherapy with PD-1/L1 Inhibitors: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTs).

    المؤلفون: Long, Yi-Xiu1 (AUTHOR) longyixiu2021@163.com, Sun, Yue2 (AUTHOR) sunyue9811@163.com, Liu, Rui-Zhi3 (AUTHOR) liuruizhi2003@163.com, Zhang, Ming-Yi1 (AUTHOR) zhangmingyi319@163.com, Zhao, Jing1 (AUTHOR) greencandy1216@163.com, Wang, Yu-Qing1 (AUTHOR) 2020224020143@stu.scu.edu.cn, Zhou, Yu-Wen1 (AUTHOR) drzhouyuwen@163.com, Cheng, Ke1 (AUTHOR) chengke@wchscu.cn, Chen, Ye1 (AUTHOR) huaxichenye@163.com, Zhu, Cai-Rong2 (AUTHOR) cairong.zhu@hotmail.com, Liu, Ji-Yan1,4,5 (AUTHOR) liujiyan1972@163.com

    المصدر: Current Oncology. Feb2022, Vol. 29 Issue 1, p267-282. 16p. 1 Diagram, 5 Charts, 3 Graphs.

    مصطلحات موضوعية: *RANDOMIZED controlled trials, *PNEUMONIA, *CANCER chemotherapy, *MTOR inhibitors, *COMBINATION drug therapy, *PROGRAMMED cell death 1 receptors, *PNEUMONIA prevention, *THERAPEUTIC use of antineoplastic agents, *ONLINE information services, *META-analysis, *CONFIDENCE intervals, *MEDICAL information storage & retrieval systems, *MEDICAL databases, *INFORMATION storage & retrieval systems, *SYSTEMATIC reviews, *TREATMENT effectiveness, *IMMUNOLOGIC diseases, *MEMBRANE proteins, *IMMUNOSUPPRESSIVE agents, *ODDS ratio, *MEDLINE, *CHEMICAL inhibitors

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث